With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, with and without type 2 diabetes, this portion of the tria ...
With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, ...
VCs and universities struggle with different goals and timelines, but tech transfer is helping turn academic science into ...
The Gratiot Life Sciences Building will house a joint venture between BAMF Health and Henry Ford Health for cancer treatment and research. This new development is located on the site of a previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results